Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Mayo Clinic
City of Hope Medical Center
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Stanford University
Emory University
Calibr, a division of Scripps Research
Calibr, a division of Scripps Research
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Stanford University
Stanford University
Dartmouth-Hitchcock Medical Center
Brown University
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
University of Michigan Rogel Cancer Center
Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
University of Wisconsin, Madison
Alliance for Clinical Trials in Oncology
Ohio State University Comprehensive Cancer Center
Swiss Cancer Institute
Wake Forest University Health Sciences
Ohio State University Comprehensive Cancer Center
Cancer Research UK
Masonic Cancer Center, University of Minnesota
Massachusetts General Hospital
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
City of Hope Medical Center
City of Hope Medical Center
University of California, San Francisco
Indiana University
Barbara Ann Karmanos Cancer Institute
Rutgers, The State University of New Jersey
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Duke University
City of Hope Medical Center
Jonsson Comprehensive Cancer Center
Northwestern University